Wendy Carruthers Boston Scientific Corp (BSX) insider trading activity

Wendy Carruthers is EVP, Human Resources of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 29,308 shares of BSX, which is worth approximately $3.12 Million. The most recent transaction as insider was on May 15, 2023, when has been sold 6,408 shares (Common Stock) at a price of $14.7 per share, resulting in proceeds of $94,197. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.3K

0% 3M change

35.77% 12M change

Total Value Held $3.12 Million

Wendy Carruthers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 6.66%	89,781 Common Stock
Apr 17 2023	SELL Open market or private sale	$606,425 $51.96 p/Share	11,671 Reduced 12.28%	83,373 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 6.32%	95,044 Common Stock
Mar 15 2023	SELL Open market or private sale	$555,539 $47.6 p/Share	11,671 Reduced 11.64%	88,636 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	$94,197 $14.7 p/Share	6,408 Added 6.0%	100,307 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$31,944 $46.23 p/Share	691 Reduced 0.73%	93,899 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	1,558 Added 1.62%	94,590 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$38,255 $46.54 p/Share	822 Reduced 0.88%	93,032 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	1,853 Added 1.94%	93,854 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$46,446 $46.54 p/Share	998 Reduced 1.07%	92,001 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	2,250 Added 2.36%	92,999 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$42,296 $46.48 p/Share	910 Reduced 0.99%	90,749 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	2,050 Added 2.19%	91,659 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$34,852 $47.29 p/Share	737 Reduced 0.82%	89,609 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	1,661 Added 1.81%	90,346 Common Stock
Feb 10 2023	SELL Bona fide gift	-	2,195 Reduced 2.42%	88,685 Common Stock
Jan 01 2023	SELL Payment of exercise price or tax liability	$143,437 $46.27 p/Share	3,100 Reduced 3.3%	90,880 Common Stock
Jan 01 2023	BUY Exercise of conversion of derivative security	-	6,567 Added 6.53%	93,980 Common Stock
Dec 15 2022	SELL Open market or private sale	$349,650 $46.62 p/Share	7,500 Reduced 7.9%	87,413 Common Stock
Nov 15 2022	SELL Open market or private sale	$71,482 $42.6 p/Share	1,678 Reduced 1.74%	94,913 Common Stock
Oct 17 2022	SELL Open market or private sale	$539,807 $40.52 p/Share	13,322 Reduced 12.12%	96,591 Common Stock
Sep 15 2022	SELL Open market or private sale	$316,575 $42.21 p/Share	7,500 Reduced 6.39%	109,913 Common Stock
Aug 15 2022	SELL Open market or private sale	$315,225 $42.03 p/Share	7,500 Reduced 6.0%	117,413 Common Stock
Jul 18 2022	SELL Open market or private sale	$285,000 $38.0 p/Share	7,500 Reduced 5.66%	124,913 Common Stock
Jun 24 2022	SELL Open market or private sale	$285,000 $38.0 p/Share	7,500 Reduced 5.36%	132,413 Common Stock

Also insider at

NVST

Envista Holdings Corp Healthcare

Director